🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to assess the pharmacokinetics, safety and tolerability of Selumeti...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02063230
Treatments Being Tested
This is an open-label, non-randomized, multicenter phase Ib/II study, which...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2014-09
Trial ID
NCT02025114
Treatments Being Tested
Background: Gastrointestinal stromal tumors (GIST) can cause serious medic...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-04-07
Trial ID
NCT03109301
Treatments Being Tested
A study to assess the pharmacokinetics, safety and tolerability of Selumeti...
Status
Completed
Location
Research Site
Start Date
2014-03
Trial ID
NCT02063204
Treatments Being Tested
To determine the clinical benefit rate of selumetinib in combination with s...
Status
Completed
Location
Children's National Medical Center
Start Date
2019-10-02
Trial ID
NCT03433183
Treatments Being Tested
The objective of this study is to investigate the safety and tolerability o...
Status
Terminated
Location
AZD6244 PhI Japanese Gem/
Start Date
2013-10
Trial ID
NCT01949870
Treatments Being Tested
To determine the maximum tolerated dose (MTD) of AZD6244 or AZD2171 when co...
Status
Terminated
Location
The Christie NHS Foundation Trust
Start Date
2010-07
Trial ID
NCT01160926
Treatments Being Tested
This study focused on patients with type I neurofibromatosis undergoing sur...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06621082
Treatments Being Tested
Cancer is a leading cause of death in individuals living with human immunod...
Status
Terminated
Location
Brighton and Sussex University Hospitals
Start Date
2012-06-15
Trial ID
NCT01752569
Treatments Being Tested
This study focused on patients with type I neurofibromatosis, who currently...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620354
Treatments Being Tested